Columbia University

Technology Ventures

Latest News

Omega-3 fatty acids reduced brain damage in a neonatal mouse model of stroke, a study from researchers at Columbia University Medical Center (CUMC) has found.
Cara Greene, a toddler from North Carolina, began losing strength in her arms and limbs at the age of 15 months. In a matter of months, she lost her ability to walk, feed herself, and pick up even the smallest of toys.
We’re all accustomed to having appliances on our kitchen counters, from toasters and blenders to coffee makers and microwaves. If Mechanical Engineering Professor Hod Lipson has his way, we’ll soon need to make room for one more—a 3D food printer that could revolutionize the way we think about food and prepare it.
A new study may explain why people who do not have celiac disease or wheat allergy nevertheless experience a variety of gastrointestinal and extra-intestinal symptoms after ingesting wheat and related cereals.
In the big data era, the modern computer is showing signs of age. The sheer number of observations now streaming from land, sea, air and space has outpaced the ability of most computers to process it. As the United States races to develop an “exascale” machine up to the task, a group of engineers and scientists at Columbia have teamed up to pursue solutions of their own.
Sapience Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics to address difficult to treat oncology indications, announced that it has raised $22.5 million in a Series A financing.
Columbia University is among the Top 100 Worldwide Universities Granted U.S. Utility Patents Ranking for 2015.
VidRovr, an innovative video management and processing platform developed by PhD students in Columbia Engineering’s Digital and Multimedia Lab, has been named among the Publicis90, a select group of start-ups that will receive funding and a year of guidance from executive mentors at Publicis Groupe.
The consortium aligns four major academic institutions in a unified partnership with the shared goal of creating high-impact research programs to discover new treatments for cancer.